Citation Impact
Citing Papers
Rhizobium induces DNA damage in Caenorhabditis elegans intestinal cells
2019 StandoutNobel
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
2017 Standout
Correlation of PD-L1 Tumor Expression and Treatment Outcomes in Patients with Renal Cell Carcinoma Receiving Sunitinib or Pazopanib: Results from COMPARZ, a Randomized Controlled Trial
2014
Inherent DNA ‐binding specificities of the HIF ‐1α and HIF ‐2α transcription factors in chromatin
2018 StandoutNobel
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models
2016 StandoutNatureNobel
HIF-independent synthetic lethality between CDK4/6 inhibition and VHL loss across species
2019 StandoutNobel
Sarcomatoid renal cell carcinoma: genomic insights from sequencing of matched sarcomatous and carcinomatous components
2016
QuPath: Open source software for digital pathology image analysis
2017 Standout
Mechanisms of hypoxia signalling: new implications for nephrology
2019 StandoutNobel
Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial
2016
Mutant p53 induces a hypoxia transcriptional program in gastric and esophageal adenocarcinoma
2019 StandoutNobel
Targeting HIF2 in Clear Cell Renal Cell Carcinoma
2016 StandoutNobel
Hypoxia-Inducible Factors: Master Regulators of Cancer Progression
2016 StandoutNobel
Delivery technologies for cancer immunotherapy
2019 Standout
Clinical and immunologic correlates of response to PD-1 blockade in a patient with metastatic renal medullary carcinoma
2017
Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer
2015
PD-L1 expression and prognostic impact in glioblastoma
2015
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
Role of PD-1 in Immunity and Diseases
2017 StandoutNobel
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
2016 Standout
Overcome tumor heterogeneity-imposed therapeutic barriers through convergent genomic biomarker discovery: A braided cancer river model of kidney cancer
2016
Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy
2015
Immune checkpoint inhibitors: recent progress and potential biomarkers
2018 Standout
Renal cell carcinoma
2017 Standout
Systemic Therapy for Metastatic Renal-Cell Carcinoma
2017
Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma
2016
Inactivation of the PBRM1 tumor suppressor gene amplifies the HIF-response in VHL −/− clear cell renal carcinoma
2017 StandoutNobel
Echinococcosis: Advances in the 21st Century
2019 Standout
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
2016 Standout
CD274/PD-L1gene amplification and PD-L1 protein expression are common events in squamous cell carcinoma of the oral cavity
2016
The role of hypoxia‐inducible factors in carotid body (patho) physiology
2018 StandoutNobel
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
2015 Standout
BAF180: Its Roles in DNA Repair and Consequences in Cancer
2017
The VHL Tumor Suppressor Gene: Insights into Oxygen Sensing and Cancer.
2017 StandoutNobel
CTLA-4 and PD-1 Pathways
2015 Standout
Prognostic Role of PD-L1 in Malignant Solid Tumors: A Meta-Analysis
2017
PD-1 blockade therapy in renal cell carcinoma: Current studies and future promises
2015
Works of Melissa Stanton being referenced
PD-1 and PD-L1 Expression in Renal Cell Carcinoma with Sarcomatoid Differentiation
2015
Whole-Exome Sequencing in Two Extreme Phenotypes of Response to VEGF-Targeted Therapies in Patients With Metastatic Clear Cell Renal Cell Carcinoma
2016
PD-L1 expression in nonclear-cell renal cell carcinoma
2014
Correlation Between Molecular Subclassifications of Clear Cell Renal Cell Carcinoma and Targeted Therapy Response
2015
Comprehensive profiling of renal medullary and collecting duct carcinomas.
2016
PD-L1 expression in non-clear cell renal cell carcinoma and benign kidney tumors.
2014
PD-L1 expression in non-clear cell renal cell carcinoma.
2014